2021-08-26 17:35:38
It’s a bait and switch approval:
“The FDA acknowledges that while Pfizer has ‘insufficient stocks’ of the newly licensed Comirnaty vaccine available, there is ‘a significant amount’ of the Pfizer-BioNTech COVID vaccine — produced under Emergency Use Authorization (EUA) — still available for use.
The FDA decrees that the Pfizer-BioNTech vaccine under the EUA should remain unlicensed but can be used ‘interchangeably’ (page 2, footnote 8) with the newly licensed Comirnaty product.
Second, the FDA pointed out that the licensed Pfizer Comirnaty vaccine and the existing, EUA Pfizer vaccine are ‘legally distinct,’ but proclaims that their differences do not ‘impact safety or effectiveness’.”
2.4K views14:35
E
